Goodwin Procter advised HIBio on the deal while Orrick represented MorphoSys. HIBio announced its equity participation agreement and license agreements with MorphoSys AG (FSE: MOR; NASDAQ: MOR)....
HIBio’s License Agreements with MorphoSys AG
Pluto’s $4 Million Seed Round
Goodwin Procter advised at.inc/ on the deal. at.inc/ acted as lead investor in a $4 million dollar seed round in Pluto. The round included Switch Ventures...
ImCheck Therapeutics’ €96 Million Fundraising
Dentons Paris advised ImCheck Therapeutics on the transaction. McDermott Will & Emery advised McDermott advised EarlyBird and Andera Partners. Goodwin advised Bpifrance. Bpifrance, through its InnoBio...
EcoVadis’ $500 Million Fundraising
Jones Day advised EcoVadis on the deal. Orrick advised Princeville Capital. Goodwin Procter represented Astorg. EcoVadis, a leading global sustainability rating firm, announced its $500 million fundraising....
TelcoSwitch’s Equity Investment by Queen’s Park Equity
Osborne Clarke has advised the shareholders of TelcoSwitch on the deal while Goodwin Procter represented Queen’s Park Equity. TelcoSwitch on a private equity investment by Queen’s...
WIND Ventures’ Investment in Yummy
Goodwin Procter advised WIND Ventures on the deal. WIND Ventures (Copec Overseas SpA) announced its investment in Yummy. In addition to WIND Ventures, the round was led...
Ivella’s $3.5 Million Seed Round Financing
Goodwin Procter advised Ivella on the deal. Ivella announced the completion of its $3.5 million seed round, which was led by Anthemis, Financial Venture Studio and Soma...
Shellworks’ $6.2 Million Seed Financing Round
Goodwin Procter advised Shellworks on the deal. Shellworks announced its $6.2 million seed financing round led by London-based VC LocalGlobe, backer of firms like TweetDeck and TransferWise....
Moka.care’s €15 Million Series A Financing
Goodwin Procter advised Left Lane Capital on the deal. Left Lane Capital announced the €15 million Series A financing of Moka.care, a French startup that focuses on...
Sichuan Kelun-Biotech Biopharmaceutical’s License Agreement with Merck
Goodwin Procter advised Sichuan Kelun-Biotech Biopharmaceutical Co. on the deal. Sichuan Kelun-Biotech Biopharmaceutical Co. announced its exclusive license and collaboration agreement with Merck for ex-China development...
Advent International’s Fundraising
Goodwin advised Advent International on the deal. Advent International announced its fundraising for its flagship fund, Advent International GPE X. The fund reached its hard cap of...
Tranch’s US$4.25 Million Pre-seed Equity and Debt Funding
Goodwin advised Tranch on the deal. Tranch announced its US$4.25 million pre-seed equity and debt funding. The funding round is led by Flash Ventures the pre-seed investor...